Abstract
Evolving from an era of predominantly diagnosing and monitoring pregnancies at risk of adverse outcomes, scientific perspective and clinical work are now increasingly shifting towards early prediction and the development of options for the prevention of untoward pregnancy events. One such event of paramount importance is Fetal growth restriction (FGR). Clearly, given that FGR fetuses are at increased risk of perinatal mortality and morbidity (Gardosi et al BMJ 2013; 346: f108) and poor long term outcome, the identification of early predictive markers might enhance the development of more targeted treatment options, which would be an important advance.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: BJOG : an international journal of obstetrics and gynaecology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
